179 related articles for article (PubMed ID: 35523034)
1. Joint association of statins and testosterone replacement therapy with cardiovascular disease among older men with prostate cancer: SEER-Medicare 2007-2015.
Lopez DS; Kim H; Polychronopoulou E; Taha S; Tsilidis KK; Villasante-Tezanos A; Peek MK; Gilani S; Khera M; Baillargeon J; Kuo YF; Canfield S
Cancer Epidemiol; 2022 Aug; 79():102172. PubMed ID: 35523034
[TBL] [Abstract][Full Text] [Related]
2. The role of testosterone replacement therapy and statin use, and their combination, in prostate cancer.
Lopez DS; Huang D; Tsilidis KK; Canfield S; Khera M; Baillargeon JG; Kuo YF; Peek MK; Platz EA; Markides K
Cancer Causes Control; 2021 Sep; 32(9):965-976. PubMed ID: 34041642
[TBL] [Abstract][Full Text] [Related]
3. Effect of statins and testosterone replacement therapy on incident cardiovascular disease among male hormone-related cancer survivors.
El Haddad D; Kim H; Polychronopolou E; Baillargeon J; Villasante-Tezanos A; Kuo YF; Gilani S; Khalife WI; Lopez DS
Res Sq; 2023 Nov; ():. PubMed ID: 37961677
[TBL] [Abstract][Full Text] [Related]
4. Independent and Joint Effects of Testosterone Replacement Therapy and Statins use on the Risk of Prostate Cancer Among White, Black, and Hispanic Men.
Lopez DS; Polychronopoulou E; Tsilidis KK; Khera M; Su LJ; Fowke JH; Peek MK; Kuo YF; Markides K; Canfield S
Cancer Prev Res (Phila); 2021 Jul; 14(7):719-728. PubMed ID: 33879532
[TBL] [Abstract][Full Text] [Related]
5. Metformin and testosterone replacement therapy inversely associated with hormone-associated cancers (prostate, colorectal and male breast cancers) among older White and Black men.
Lopez DS; Malagaris I; Polychronopoulou E; Tsilidis KK; Milani SA; Kristen Peek M; Villasante-Tezanos A; Alzweri L; Baillargeon J; Kuo YF; Canfield S
Clin Endocrinol (Oxf); 2022 Dec; 97(6):792-803. PubMed ID: 35902376
[TBL] [Abstract][Full Text] [Related]
6. Use of weight loss medications in relation with prostate, colorectal and male breast cancers among older men: SEER-Medicare 2007-2015.
Lopez DS; Kim H; Polychronopoulou E; Torres-Sanchez LE; Villasante-Tezanos A; Baillargeon J; Canfield S; Kuo YF
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8255-8265. PubMed ID: 37067547
[TBL] [Abstract][Full Text] [Related]
7. Association of the extent of therapy with prostate cancer in those receiving testosterone therapy in a US commercial insurance claims database.
Lopez DS; Huang D; Tsilidis KK; Khera M; Williams SB; Urban RJ; Panagiotou OA; Kuo YF; Baillargeon J; Farias A; Krause T
Clin Endocrinol (Oxf); 2019 Dec; 91(6):885-891. PubMed ID: 31498469
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the impact of pre-diagnostic use of statins and testosterone replacement therapy on mortality outcomes in older men with hormone-related cancers: Surveillance, Epidemiology, and End Results-Medicare 2007-2015.
Hussain MR; Abdelgadir O; Polychronopoulou E; Tsilidis KK; Alzweri L; Villasante-Tezanos A; Baillargeon J; Canfield S; Kuo YF; Lopez DS
Andrology; 2024 Feb; ():. PubMed ID: 38421134
[TBL] [Abstract][Full Text] [Related]
9. Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer.
Tan XL; E JY; Lin Y; Rebbeck TR; Lu SE; Shang M; Kelly WK; D'Amico A; Stein MN; Zhang L; Jang TL; Kim IY; Demissie K; Ferrari A; Lu-Yao G
Cancer Med; 2020 Apr; 9(7):2379-2389. PubMed ID: 32035002
[TBL] [Abstract][Full Text] [Related]
10. Trends in Testosterone Therapy use in Prostate Cancer Survivors in the United States.
Chen T; Li S; Eisenberg ML
J Sex Med; 2021 Aug; 18(8):1346-1353. PubMed ID: 34303630
[TBL] [Abstract][Full Text] [Related]
11. Testosterone Replacement Therapy in Relation With Cardiovascular Disease in Cisgender Women and Transgender People.
Lopez DS; Mulla JS; El Haddad D; Tahashilder MI; Polychronopolou E; Baillargeon J; Kuo YF; Gilani S; Khalife WI
J Clin Endocrinol Metab; 2023 Nov; 108(12):e1515-e1523. PubMed ID: 37392459
[TBL] [Abstract][Full Text] [Related]
12. Safety of testosterone therapy in men with prostate cancer.
Morgentaler A; Caliber M
Expert Opin Drug Saf; 2019 Nov; 18(11):1065-1076. PubMed ID: 31495240
[No Abstract] [Full Text] [Related]
13. Cardiovascular disease prevention and management of pre-existent cardiovascular disease in a cohort of prostate cancer survivors.
Katz AJ; Chen RC; Usinger DS; Danus SM; Zullig LL
J Cancer Surviv; 2023 Apr; 17(2):351-359. PubMed ID: 35790675
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data.
Alwani M; Yassin A; Talib R; Al-Qudimat A; Aboumarzouk O; Al-Zoubi RM; Saad F; Haider KS; Al Ansari A
Vasc Health Risk Manag; 2021; 17():497-508. PubMed ID: 34465997
[TBL] [Abstract][Full Text] [Related]
15. Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study.
Freedland SJ; Hamilton RJ; Gerber L; Banez LL; Moreira DM; Andriole GL; Rittmaster RS
Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):254-9. PubMed ID: 23567655
[TBL] [Abstract][Full Text] [Related]
16. Controversies in Testosterone Therapy.
Twitchell DK; Pastuszak AW; Khera M
Sex Med Rev; 2021 Jan; 9(1):149-159. PubMed ID: 33309270
[TBL] [Abstract][Full Text] [Related]
17. Testosterone therapy and cancer risks among men in the SEER-Medicare linked database.
Butler EN; Zhou CK; Curry M; McMenamin Ú; Cardwell C; Bradley MC; Graubard BI; Cook MB
Br J Cancer; 2023 Jan; 128(1):48-56. PubMed ID: 36307648
[TBL] [Abstract][Full Text] [Related]
18. Testosterone therapy in prostate cancer: is it still a controversy?
Bart AS; Van Hoof A; Badre-Hume R; Selvarajah J; Robillard K; Albala DM
Curr Opin Urol; 2022 Nov; 32(6):598-606. PubMed ID: 36081393
[TBL] [Abstract][Full Text] [Related]
19. The Suggested Unique Association Between the Various Statin Subgroups and Prostate Cancer.
Goldberg H; Mohsin FK; Saskin R; Kulkarni GS; Berlin A; Kenk M; Wallis CJD; Klaassen Z; Chandrasekar T; Ahmad AE; Sayyid RK; Saarela O; Penn L; Alibhai SMH; Fleshner N
Eur Urol Focus; 2021 May; 7(3):537-545. PubMed ID: 32620539
[TBL] [Abstract][Full Text] [Related]
20. Association of statin use with risk of Gleason score-specific prostate cancer: A hospital-based cohort study.
Wang K; Gerke TA; Chen X; Prosperi M
Cancer Med; 2019 Dec; 8(17):7399-7407. PubMed ID: 31595713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
